08
May
09

Federal HIV/AIDS Funding Priorities for FY2010

May 7, 2009 – Washington, DC – The Obama administration released details about HIV/AIDS funding in the FY2010 budget. During a conference call in which the National Minority AIDS Council (NMAC) participated, White House Officials noted that the Department of Health and Human Services (HHS) budget will be $78.4 billion a $2.6 billion increase from last year.

“This is a great time for the HIV/AIDS movement, with the epidemic once again becoming a priority in the government’s agenda,” said Paul Kawata, Executive Director of NMAC. “We are moving toward a national health strategy that will address the funding necessary to target the HIV/AIDS epidemic and other health disparities in the U.S.”

The $78.4 billion will breakdown as follows: $53 million will be geared to the Centers for Disease Control and Prevention’s (CDC) HIV budget, including HIV/AIDS prevention, testing, linkages to services, increasing capacity, and health department monitoring; $54 million will be directed to the Ryan White Care Act; HOPWA will have a modest increase; and abstinence-only budgets will be 75% reallocated into comprehensive, evidence-based teen pregnancy prevention education and 25% geared to fund new HIV/AIDS interventions. In addition, the National Institutes of Health (NIH) will receive $443 million increase in funding, where $6 billion will be for cancer research over eight years.

“This budget will significantly increase prevention efforts to address the staggering rate of new HIV cases that take place annually in the U.S., which is most welcome considering the frightening spike in HIV/AIDS rates throughout our country, especially among people of color and our nation’s capital”, said Ravinia Hayes-Cozier, NMAC’s Director of Government Relations and Public Policy Division. “Although the ban on funding for syringe exchange will not be lifted, we will continue our intensive advocacy work for it. Also, funding to support getting people into care is crucial to the success of a National AIDS Strategy, where the lack of access to HIV/AIDS treatment and care has been a continuous concern since the epidemic began.”

The HHS budget justifications will be publicly available within the next few days and include more details.

This content was adapted from a National AIDS Minority Council Bulletin. More information will be posted as it is released.

12
Mar
09

FDA Approves New Female Condom

On Wednesday, the Female Health Company announced that the FDA has approved its FC2 Female Condom for use in preventing pregnancy and sexually transmitted infections, including HIV.
This FC2 condom has the same design and the same instructions for use as the common FC1 female condom many of us are familiar with. However, the new female condom is made of synthetic rubber rather than polyurethane, making it about 30% less expensive than the original version. Also, the FC2 is manufactured through a less-expensive process than the company’s original version, which should allow health groups to distribute larger quantities to women in Africa and other areas heavily impacted by HIV/AIDS.
With the FDA approval, the lower-cost, new version of the female condom will now be available in the United States.
Following this link will allow you to view a PDF information sheet on the FC2: http://www.femalehealth.com/pdf/FC2%20Information%20Sheet.pdf
And you can learn more about the Female Health Company, and both the FC1 and FC2 female condoms by visiting their website: http://www.femalehealth.com/
FC2 Female Condom

11
Mar
09

When should HAART be initiated in asymptomatic HIV+ patients?

Medical doctors and HIV researches Mari Kitahata and Jonathan Sterne presented the results of several studies addressing this complex question at the 16th Annual Conference on Retroviruses and Opportunistic Infections, which was held on February 9, 2009. 

Recently updated U.S. guidelines recommend initiating HAART (highly active antiretroviral therapy) in all asymptomatic HIV positive patients with a CD4 count of less than 350.  Kitahata and Stern, in this presentation/interview, review emerging data that indicates that introducing therapy even earlier in HIV disease, at CD4 counts greater than 500, could significantly prolong an individual’s survival. 

To read the complete transcript, follow this URL: http://www.thebody.com/content/confs/croi2009/art50496.html

27
Feb
09

Man arrested for mailing President Obama a letter stained with HIV-infected blood

The following material was adapted from FoxNews.com’s original article.  To see the entire piece, visit http://www.foxnews.com/politics/first100days/2009/02/27/chicago-man-arrested-allegedly-targeting-obama-hiv-infected-blood/  Please read about this interesting case below:

A man from President Obama’s hometown of Chicago has been arrested for allegedly sending Obama and his staff envelopes containing HIV-infected blood, in the hopes of killing or harming them. 

It’s only the second time ever that HIV-infected blood has been sent with malicious intent through the U.S. mail system, a spokesman for the U.S. Postal Inspection Service said.

In the weeks leading up to Obama’s inauguration, Saad Hussein, an Ethiopian refugee in his late 20’s, sent an envelope addressed to “Barack Obama” to offices of the Illinois government in Springfield, Ill., according to court documents. The envelope contained a series of unusual items, including a letter with reddish stains and an admission ticket for Obama’s election-night celebration in Chicago’s Grant Park. Court documents said Hussein, who takes drugs to treat a mental illness, later told FBI agents he is “very sick with HIV” and cut his fingers with a razor so he could bleed on the letter.

Hazmat teams were called in after the envelope was opened, and offices of the Illinois Department on Aging and the Department of Revenue were locked down for nearly two hours, locking 300 staffers in their offices, court documents said.

Hussein, with his brother acting as an interpreter, told FBI agents he was actually “an admirer” of Obama and was “seeking help from the government,” according to court documents. He also told them he was hoping to obtain tickets to the inaugural ceremonies in Washington, the documents said.

Days after sending the letter to Obama, Hussein allegedly placed two more letters in the mail, one addressed to “Emanuel,” an apparent reference to Obama’s current chief of staff, Rahm Emanuel. The two letters contained what appeared to be dried blood, the court documents said.

Hussein, who has never held a job in the three years he’s been in the United States, was arrested last month. An affidavit filed at the time accused Hussein of “knowingly” mailing letters “containing HIV-infected blood, with the intent to kill or injure another,” in violation of federal law.

The affidavit does not address whether the letters could have actually killed or injured anyone. According to the Centers for Disease Control and Prevention, HIV is spread only through sexual contact with an infected person, through sharing needles with an infected person, or through blood transfusions of infected blood.

After Hussein’s arrest, he was placed in a Chicago correctional facility. He has yet to be formally charged. A judge ordered he receive a mental examination to see if he’s fit for trial, but as of two weeks ago the court couldn’t locate a translator to conduct the examination, according to court documents.

A publicly-appointed attorney representing Hussein declined comment, saying he was “not at liberty to discuss pending criminal matters.”

The latest case marks the second time HIV-infected blood has been sent through the U.S. mail. In 2006 a “disturbed individual” placed a plastic vial of HIV-infected blood in the mail, according to Rendina. The unidentified individual was arrested and charged, and is now receiving psychiatric treatment at a federal medical detention center, Rendina said.

A clarifying note from VT CARES:

Handling a letter stained with the dried blood of an HIV positive individual would NOT put a person at risk for contracting HIV/AIDS.  This is partly because HIV dies very quickly once it is exposed to air, and also because the blood (and only if it had not yet dried…) would have to get into a person’s blood stream in order to potentially infect them. 

To obtain data on the survival of HIV, laboratory studies usually use artificially high concentrations of laboratory-grown virus. Although these concentrations of HIV can be kept alive for days or even weeks under controlled conditions, studies have shown that drying of these high concentrations of HIV reduces the amount of infectious virus by 90 to 99 percent within a few hours.

Since the HIV concentrations used in laboratory studies are much higher than those actually found in blood or other specimens, the real risk of HIV infection from dried bodily fluids is effectively zero.

That being said, HIV is present in four bodily fluids (blood, semen, vaginal secretions, and breast milk), and can be transmitted in the following ways:

1) Unprotected penetrative sex with someone who is infected

2) Injection or transfusion of contaminated blood or blood products, donations of semen (artificial insemination), skin grafts or organ transplants taken from someone who is infected.

3) From a mother who is infected to her baby; this can occur during pregnancy, at birth and through breastfeeding.

4) Sharing unsterilised injection equipment that has previously been used by someone who is infected.

If you would like clarification, or have any additional questions regarding the transmission of HIV, please don’t hesitate to contact VT CARES at (802) 863-2437. 

 

10
Feb
09

Biotech firm launches small scale human trials of new HIV/AIDS treatment

Sangamo BioSciences’, a California-based biotechnology company, recently announced plans to commence human trials of a new potential HIV/AIDS treatment that would function by targeting patients’ DNA.  The drug, oh-so-conveniently titled SB-728-T, has been designed to disrupt the CCR5 gene, which is a protein on the surface of those human immune cells to which HIV likes to attach itself in order to proliferate. 

Phase 1 of this small-scale study will involve removing the CD4+ T cells of 12 individuals living with advanced HIV disease.  The cells would then be treated, outside of the body, with the SB-728-T drug, which is also called a “zinc finger nuclease.”  Following this treatment, the cells would be infused back into the patient in hopes that they will flourish and multiply, leaving the patient’s immune system highly resistant to HIV.  The ultimate purpose of this initial phase is to examine the safety of this new, potential HIV therapy.

For additional information, of to see the original article on Kaiser Family Foundation’s website, please visit the following URL: http://www.thebody.com/content/news/art50405.html

15
Dec
08

FDA approves a new, less costly female condom

Reported by Reuters, a Food and Drug Administration advisor panel voted unanimously on Thursday, December 11th, to recommend approval of the new, less expensive version of the female/internal condom developed by the Female Health Company.  It is hoped that this new nitrile-based version of the female/internal condom, called FC2, will be attractive because of it’s lowered price point, hopefully encouraging use by greater numbers of women and allowing organizations to increase distribution in an effort to hinder the spread of HIV/AIDS. 

To learn more, please visit the following URL:

http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=56074

12
Dec
08

Peering into the future of pandemic infectious disease

Please take a look at this fascinating and informative Discover Magazine article, written by Jared Diamond and Nathan Wolfe and published in October of 2008.  The article addresses the following question: where will the next pandemic emerge?  However, the article also provides a thorough, well-written, and intriguing anecdotal history of infectious disease, of human and non-human vectors for disease transmission, and of the impact of human culture and behavior on the spread of viral, bacterial, and fungal infections.  The article touches on the most concerning epidemic of modern times, HIV/AIDS, as well as a variety of other infectious pathogens from anthrax and African sleeping sickness to SARS and syphilis.  And as for predictions regarding the future of pandemic infectious disease, Diamond and Wolfe warn that cholera, influenza, and tuberculosis are pathogens worth keeping an eye on. 

http://discovermagazine.com/2008/nov/27-where-will-the-next-pandemic-emerge

11
Dec
08

Good news…Needle-Exchange Programs gaining acceptance nationwide

Advocates Optimistic About Needle-Exchange Program Approval in Bexar County, Texas

Advocates in Bexar County, Texas, on Tuesday said they are optimistic that the next state legislative session would pass a bill authorizing local health departments to operate needle-exchange programs aimed at reducing the spread of HIV and other bloodborne diseases, the San Antonio Express-News reports. Texas State Rep. Ruth Jones McClendon (D) and Sens. Leticia Van de Putte (D) and Robert Deuell (R) plan to reintroduce bills similar to legislation introduced in previous sessions in support of needle-exchange programs.

William Martin, senior fellow for drug policy at the James A. Baker III Institute for Public Policy at Rice University, said he believes there is “a good chance” that a reintroduced needle-exchange bill “will succeed.” Martin, who has studied and testified in support of exchange programs during the past two legislative sessions, said that providing injection drug users “with access to sterile syringes allows us to be responsible, prudent and compassionate,” adding, “[T]hese are good criteria for public policy.” Charlene Doria-Ortiz, community health coordinator for Bexar County, said local officials are prepared to implement a needle-exchange program if the new bill passes, because health workers last year began organizing a pilot exchange program before a legal challenge halted their efforts (Finley, San Antonio Express-News, 12/10).

In 2007, the state Legislature authorized Bexar County to establish a pilot needle-exchange program. McClendon said lawmakers hoped to use the pilot program to consider passing a statewide program during the 2009 legislative session. However, District Attorney Susan Reed in August 2007 challenged the legislation, saying that anyone in possession of drug paraphernalia would be breaking the law, regardless of their intentions. State Attorney General Greg Abbott (R) earlier this year backed Reed, saying people who possess drug paraphernalia could be prosecuted because the law does not specifically exempt them. Abbott’s opinion meant that Bexar County officials did not move forward with the planned needle-exchange program, which would have been the first in Texas (Kaiser Daily HIV/AIDS Report, 7/23).

Police also arrested three volunteers from the Bexar Area Harm Reduction Coalition who had been openly operating an exchanging program. Neel Lane, an attorney who represents the coalition, said the arrests brought national attention to needle-exchange programs and “provided support for people already doing heroic work” (San Antonio Express-News, 12/10).

This post is a direct reprint of the original article by Kaiser Family Foundation, which can be viewed by visiting the following URL:

http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=56026

08
Dec
08

Unbelievable…

Anti-retroviral drugs used to treat HIV/AIDS are being bought and smoked by South African teenagers to get high. 

The South African Broadcasting Corporation created a documentary investigating this issue, and found that HIV/AIDS drugs are being sold by both patients and medical staff for money.  Schoolchildren, often in their uniforms, have been found across the country smoking HIV anti-retrovirals, which are ground into a fine powder and are occasionally mixed with painkillers or marijuana.  Additionally, some HIV/AIDS patients have been found smoking their drugs, instead of taking them as prescribed. 

To read the full report about this shocking discovery, please visit the following URL:

http://news.bbc.co.uk/2/hi/africa/7768059.stm

12
Nov
08

Our friend Mistress Maeve on HIV among older Americans

Dear Mistress Maeve,

My 52-year-old mother recently starting dating again after her 31-year marriage ended. I’m happy for her, but I’m also worried. In particular, I’m concerned that she doesn’t understand the frightening realities of HIV and other sexually transmitted infections.

As her daughter, is it my place to educate her? If so, how do I make it less awkward? We’ve always had an open relationship, but this might be pushing it. Please help!

Thanks,
Dr. Daughter

————————————

Dear Dr. Daughter,

You’re right to be concerned. My friends at the Vermont Committee for AIDS Resources, Education and Services say that a 2007 Vermont Department of Health report states, “Older Vermonters (50+ years old) accounted for a greater proportion of new HIV/AIDS diagnoses in 2006-2007 (29 percent of all new diagnoses) compared to 2000-2001 (12 percent of new diagnoses).” With statistics like that, it’s imperative that older at-risk adults receive accurate prevention information.

Vermont CARES also says that health-care providers may be less likely to test for HIV and other STIs in patients over 50, making it even more important that you talk with your mom. Tell her that you’re happy she’s dating again, but times have changed. Now is not the time to be shy with your mom — give her some condoms and info about HIV and other STIs, and encourage her to talk with her doctor. You’re not asking her for details of her sex life; you’re simply making her aware of the risks because you love her and care about her well-being.

If your mother confides that she’s been engaging in risky activities, consider going for an HIV test with her — it could be a good bonding and educational experience for you both. Vermont CARES offers free, anonymous, rapid oral HIV testing. For testing times and locations, visit www.vtcares.org.

xoxo,
MM

 ___________________________________________________________________________________________

Check out Mistress Maeve’s blog (love it!) at: http://7d.blogs.com/mistress/

And for a little additional reading on HIV and AIDS among Americans over the age of 50, please take a look at November 10th’s New York Times article by Karen Barrow entitled, “Speaking out for a group once unheard of: Aging with AIDS.”  Follow the link below…

http://www.nytimes.com/2008/11/11/health/11voic.html?_r=1&scp=1&sq=Speaking%20Out%20for%20A%20Group%20Once%20Unheard-of&st=cse&oref=slogin